Mifamurtide (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mifamurtide" in English language version.

refsWebsite

Global rank English rank

2^nd place

4^th place

68^th place

117^th place

11^th place

8^th place

1,570^th place

8,280^th place

6,376^th place

4,260^th place

8,069^th place

7,681^st place

low place

doi.org

"Mifamurtide: CGP 19835, CGP 19835A, L-MTP-PE, liposomal MTP-PE, MLV 19835A, MTP-PE, muramyltripeptide phosphatidylethanolamine". Drugs in R&D. 9 (2): 131–5. 2008. doi:10.2165/00126839-200809020-00007. PMID 18298131.
Meyers PA (August 2009). "Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma". Expert Review of Anticancer Therapy. 9 (8): 1035–49. doi:10.1586/era.09.69. PMID 19671023. S2CID 29512704.
Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, et al. (February 2008). "Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group". Journal of Clinical Oncology. 26 (4): 633–8. doi:10.1200/JCO.2008.14.0095. PMID 18235123.
Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, et al. (March 2005). "Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate". Journal of Clinical Oncology. 23 (9): 2004–11. doi:10.1200/JCO.2005.06.031. PMID 15774791.
Prous J, Castaner J (1989). "ENV 2-3/MTP-PE". Drugs of the Future. 14 (3): 220. doi:10.1358/dof.1989.014.03.85085.
Brundish DE, Wade R (1985). "Synthesis of N-[2-3H]acetyl-D-muramyl-L-alanyl-D-iso-glutaminyl-L-alanyl-2-(1',2'-dipalmitoyl-sn-glycero-3'-phosphoryl)ethylamide of high specific radioactivity". J Label Compd Radiopharm. 22 (1): 29–35. doi:10.1002/jlcr.2580220105.

"Mifamurtide: CGP 19835, CGP 19835A, L-MTP-PE, liposomal MTP-PE, MLV 19835A, MTP-PE, muramyltripeptide phosphatidylethanolamine". Drugs in R&D. 9 (2): 131–5. 2008. doi:10.2165/00126839-200809020-00007. PMID 18298131.
Meyers PA (August 2009). "Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma". Expert Review of Anticancer Therapy. 9 (8): 1035–49. doi:10.1586/era.09.69. PMID 19671023. S2CID 29512704.
Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, et al. (February 2008). "Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group". Journal of Clinical Oncology. 26 (4): 633–8. doi:10.1200/JCO.2008.14.0095. PMID 18235123.
Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, et al. (March 2005). "Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate". Journal of Clinical Oncology. 23 (9): 2004–11. doi:10.1200/JCO.2005.06.031. PMID 15774791.

Meyers PA (August 2009). "Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma". Expert Review of Anticancer Therapy. 9 (8): 1035–49. doi:10.1586/era.09.69. PMID 19671023. S2CID 29512704.